Arkolith/Insider Trading/CSBR/Form 4

Ackerman Joel

DirectorCHAMPIONS ONCOLOGY, INC. (CSBR) · full profile →Form 4 · filed Jan 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2023Option exercise(M)115K$2.10$241K857K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 17, 2023Option exercise(M)100K$2.10$210K0
Oct 17, 2023Option exercise(M)15K$2.10$31K0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-000639) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML